Foundation Medicine, Inc. (FMI) - Medical Equipment - Deals and Alliances Profile

Date: November 4, 2016
Pages: 79
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: FD83F260881EN
Leaflet:

Download PDF Leaflet

Foundation Medicine, Inc. (FMI) - Medical Equipment - Deals and Alliances Profile
Summary

Foundation Medicine, Inc. (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd. is a healthcare service provider that offers cancer care services. The company offers molecular information and research services for the discovery of new cancer treatments. Foundation Medicine provides clinical products such as FoundationOne for solid tumors and FoundationOne Heme for hematologic malignancies and sarcomas. It also offers additional materials, services, and real-time data through its technology products such as Interactive Cancer Explorer. The company partners with biotech and pharmaceutical companies to develop targeted cancer therapies and active clinical trials. Foundation Medicine is headquartered in Cambridge, Massachusetts, the US.

Foundation Medicine, Inc. (FMI) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Foundation Medicine, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Foundation Medicine, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
Foundation Medicine, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Foundation Medicine, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
Foundation Medicine, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Foundation Medicine, Inc., Medical Equipment, Deal Details
Venture Financing
Cota Raises Funds through Venture Financing
Foundation Medicine Raises US$56 Million In Series B Financing
Foundation Medicine Secures Additional US$8.5 Million In Series A Venture Financing
Foundation Medicine Raises US$10 Million In Venture Financing
Foundation Medicine Raises US$25 Million In Series A Financing Round
Partnerships
Foundation Medicine Enters into Licensing Agreement with WuXi PharmaTech
Foundation Medicine Enters into Agreement with AstraZeneca
Foundation Medicine Enters into Agreement with Mirati Therapeutics
IMS Health Enters into Agreement with Foundation Medicine
Foundation Medicine Enters into Co-Development Agreement with Flatiron Health
Foundation Medicine Extends Co-Development Agreement With Clovis Oncology
Foundation Medicine Expands Co-Development Agreement With Novartis
Foundation Medicine Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center
Foundation Medicine Enters Into Agreement With Agios Pharma To Develop Cancer Diagnostics
Foundation Medicine Enters Into Agreement With Eisai For Genomic Profiling And Diagnostic Discovery
Foundation Medicine Enters Into Co-Development Agreement With Clovis Oncology
Foundation Medicine Extends Co-Development Agreement With Novartis
Foundation Medicine Enters Into Co-Development Agreement With Sanofi For Genetic Biomarkers And Potential Diagnostics
Foundation Medicine Enters Into An Agreement With Novartis
Equity Offering
Foundation Medicine Raises USD250 Million in Private Placement of Shares
Foundation Medicine Withdraws Public Offering Of Shares For Up To US$150 Million
Foundation Medicine Completes IPO Of Shares For US$122 Million
Foundation Medicine, Inc. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Financial Announcements
Nov 02, 2016: Foundation Medicine Announces 2016 Third Quarter Results and Recent Highlights
Aug 02, 2016: Foundation Medicine Announces 2016 Second Quarter Results and Recent Highlights
May 03, 2016: Foundation Medicine Announces 2016 First Quarter Results and Recent Highlights
Feb 23, 2016: Foundation Medicine Announces 2015 Fourth Quarter and Year-End Results, Recent Highlights and 2016 Outlook
Nov 03, 2015: Foundation Medicine Announces 2015 Third Quarter Results and Recent Highlights
Jul 29, 2015: Foundation Medicine Announces 2015 Second Quarter Results and Recent Highlights
May 11, 2015: Foundation Medicine Announces 2015 First Quarter Results and Recent Highlights
Feb 24, 2015: Foundation Medicine Announces 2014 Fourth Quarter and Year-End Results, Recent Highlights
Jan 12, 2015: Foundation Medicine Reports Preliminary 2014 Results
Corporate Communications
Oct 27, 2016: Foundation Medicine Adds Life Sciences Leader Michael R. Dougherty to its Board of Directors
Mar 23, 2015: Foundation Medicine Announces Executive Promotions and Expanded Leadership Team to Complement Global Growth Initiatives
Mar 23, 2015: Foundation Medicine Announces Proposed Changes to its Board of Directors in Connection with the Pending Roche Transaction
Product News
Mar 23, 2016: Foundation Medicine and Memorial Sloan Kettering Publish Validation Data for FoundationOne Heme in the Journal Blood
Mar 17, 2016: Foundation Medicine Announces Presentations at the AACR Annual Meeting 2016
Mar 16, 2016: Foundation Medicine Presents New Data at the 2016 USCAP Annual Meeting Underscoring Importance of Comprehensive Genomic Profiling in Cancer Care
May 13, 2015: Foundation Medicine's Comprehensive Genomic Profile Informs Therapeutic Choices and Leads to Promising Outcomes in Pediatric Patients With Gliomas
Apr 20, 2015: Foundation Medicine Announces Its Collaboration with the National Cancer Institute on Exceptional Responders Initiative
Feb 19, 2015: Foundation Medicine to Present New Clinical Data on Clinical Applications of FoundationOne at the 16th Annual Advances in Genome Biology and Technology Meeting
Feb 12, 2015: New Data from FoundationOne Demonstrates Genomic Basis for Potential New Routes to Therapy and Improved Outcomes for Individuals with Cancers of Unknown Primary
Jan 09, 2015: FoundationOne Identifies High Frequency of Clinically Relevant Genomic Alterations (GA) Previously Missed by Conventional Genomic Tests, Enabling Successful Targeted Treatment in Patients with Non-Small Cell Lung Cancer
Jan 08, 2015: Foundation Medicine and Collaborators to Present New Clinical Data on the Application of FoundationOne at the 2015 Gastrointestinal Cancers Symposium
Clinical Trials
Jan 09, 2015: FoundationOne Identifies High Frequency of Clinically Relevant Genomic Alterations (GA) Previously Missed by Conventional Genomic Tests, Enabling Successful Targeted Treatment in Patients with Non-Small Cell Lung Cancer
Other Significant Developments
Feb 25, 2016: Foundation Medicine Announces First-Ever Public Release of Broad Pediatric Data From FoundationCORE to Accelerate the Development of Precision Medicine Strategies for Pediatric Cancers
Nov 02, 2015: Foundation Medicine Announces Roche Pharmaceuticals (Israel) to Commence Commercial Activities in Support of its Molecular Information Products in Oncology
Sep 15, 2015: Foundation Medicine Expands Molecular Information Decision Support Offerings with GeneKit, a Genomic Solutions Portal for Pathologists
Jan 07, 2015: Foundation Medicine Launches ICE 2, Its New Version of Interactive Cancer Explorer, Featuring PatientMatch
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Foundation Medicine, Inc., Medical Equipment, Key Facts, 2015
Foundation Medicine, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Foundation Medicine, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Foundation Medicine, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
Foundation Medicine, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Foundation Medicine, Inc., Deals By Market, 2010 to YTD 2016
Foundation Medicine, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Cota Raises Funds through Venture Financing
Foundation Medicine Raises US$56 Million In Series B Financing
Foundation Medicine Secures Additional US$8.5 Million In Series A Venture Financing
Foundation Medicine Raises US$10 Million In Venture Financing
Foundation Medicine Raises US$25 Million In Series A Financing Round
Foundation Medicine Enters into Licensing Agreement with WuXi PharmaTech
Foundation Medicine Enters into Agreement with AstraZeneca
Foundation Medicine Enters into Agreement with Mirati Therapeutics
IMS Health Enters into Agreement with Foundation Medicine
Foundation Medicine Enters into Co-Development Agreement with Flatiron Health
Foundation Medicine Extends Co-Development Agreement With Clovis Oncology
Foundation Medicine Expands Co-Development Agreement With Novartis
Foundation Medicine Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center
Foundation Medicine Enters Into Agreement With Agios Pharma To Develop Cancer Diagnostics
Foundation Medicine Enters Into Agreement With Eisai For Genomic Profiling And Diagnostic Discovery
Foundation Medicine Enters Into Co-Development Agreement With Clovis Oncology
Foundation Medicine Extends Co-Development Agreement With Novartis
Foundation Medicine Enters Into Co-Development Agreement With Sanofi For Genetic Biomarkers And Potential Diagnostics
Foundation Medicine Enters Into An Agreement With Novartis
Foundation Medicine Raises USD250 Million in Private Placement of Shares
Foundation Medicine Withdraws Public Offering Of Shares For Up To US$150 Million
Foundation Medicine Completes IPO Of Shares For US$122 Million
Foundation Medicine, Inc., Key Competitors
Foundation Medicine, Inc., Key Employees
Foundation Medicine, Inc., Other Locations

LIST OF FIGURES

Foundation Medicine, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Foundation Medicine, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Foundation Medicine, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Foundation Medicine, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
Foundation Medicine, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Foundation Medicine, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Foundation Medicine, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Foundation Medicine, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016
Skip to top


Ask Your Question

Foundation Medicine, Inc. (FMI) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: